Nobel Prize in Physiology or Medicine 2024 awarded jointly to Victor Ambros and Gary Ruvkun
en-GBde-DEes-ESfr-FR

Nobel Prize in Physiology or Medicine 2024 awarded jointly to Victor Ambros and Gary Ruvkun

07.10.2024 Nobel Prize News

Nobel Prize in Physiology or Medicine 2024 awarded jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

"This year’s Nobel Prize honors two scientists for their discovery of a fundamental principle governing how gene activity is regulated", according to the Nobel Prize Committee.

They added: This year’s Nobel Prize focuses on the discovery of a vital regulatory mechanism used in cells to control gene activity. Genetic information flows from DNA to messenger RNA (mRNA), via a process called transcription, and then on to the cellular machinery for protein production. There, mRNAs are translated so that proteins are made according to the genetic instructions stored in DNA. Since the mid-20th century, several of the most fundamental scientific discoveries have explained how these processes work.

According to the BBC Science Unit, "Their work helped explain how our genes work inside the human body.

Their discoveries help explain how complex life emerged on Earth and how the human body is made up of a wide variety of different tissues.

MicroRNAs influence how genes - the instructions for life - are controlled inside organisms, including us."

Victor R. Ambros (born 1953, Hanover, New Hampshire) is an American developmental biologist who discovered the first known microRNA (miRNA). He is a professor at the University of Massachusetts Medical School in Worcester, Massachusetts. (Wikipedia)


Gary Bruce Ruvkun (born March 1952, Berkeley, California)[1] is an American molecular biologist at Massachusetts General Hospital and professor of genetics at Harvard Medical School in Boston.[2] Ruvkun discovered the mechanism by which lin-4, the first microRNA (miRNA) discovered by Victor Ambros, regulates the translation of target messenger RNAs via imperfect base-pairing to those targets, and discovered the second miRNA, let-7, and that it is conserved across animal phylogeny, including in humans. (Wikipedia)

The winners share a prize fund worth get 11m Swedish kronor (£810,000).
For more information, please check the links below:
Angehängte Dokumente
  • Winners of the 2024 Nobel Prize in Physiology or Medicine, Victor Ambros (left) and Gary Ruvkun (Ill. Niklas Elmehed © Nobel Prize Outreach)
07.10.2024 Nobel Prize News
Regions: Europe, United Kingdom, Sweden, North America, United States
Keywords: Health, Medical, People in health research

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2024 by DNN Corp Terms Of Use Privacy Statement